Home
  >  
Section 32

EurekaMag Full Text Articles Chapter 31,286



References:

Dittmer, J.; Bauer, C. 1990: Erythropoietin regulation a 50k protein with an oxygen dependent dna binding property. Pfluegers Archiv European Journal of Physiology 415(Suppl 1): R34
Dessypris, E.N.; Krantz, S.B. 1990: Erythropoietin: regulation of erythropoiesis and clinical use. Advances in Pharmacology 21: 127-147
Tran, K.H.; Udden, M.M.; Taffet, G.E.; Banez, E. 1993: Erythropoietin regulation of hematopoiesis is preserved in healthy elderly people. Clinical Research 41(2): 116A
Cui, K.; Sytkowski, A.J. 1998: Erythropoietin regulation of line-1 expression in murine erythropoiesis. Blood 92(10 Suppl 1 Part 1-2): 157B
Udupa, K.B.; Sharma, B.G.; Johnson, R.W. 1994: Erythropoietin requirement for the maintenance of normal erythropoiesis. Experimental Hematology 22(8): 709
Raja, R.; Johnson, R.; Bloom, E. 1994: Erythropoietin requirement in peritoneal patients Role of peritonitis. Journal of the American Society of Nephrology 5(3): 471
Cohen, D.; Bloom, R. 1996: Erythropoietin requirements are inversely related to iron saturation levels in chronic stable hemodialysis patients. Journal of the American Society of Nephrology 7(9): 1442
Sanchez, C.P.; Goodman, W.G.; Gales, B.; Salusky, I.B. 1994: Erythropoietin requirements in patients with secondary hyperparathyroidism. Journal of the American Society of Nephrology 5(3): 503
Knight, S.M.; Smith, M.A.; Smith, J.G.; Maddison, P.J. 1990: Erythropoietin resistance and compensatory mechanisms in anemia of rheumatoid arthritis. British Journal of Rheumatology 29(ABSTR Suppl 2): 13
Zachee, P.; Chew, S.L.; Daelemans, R.; Lins, R.L. 1992: Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment. American Journal of Nephrology 12(3): 188-191
Bernell, P.; Hippe, E.; Wallvik, J.; Hast, R. 1994: Erythropoietin resistant myelodysplastic syndromes may respond when erythropoietin is used in combination with granulocyte-macrophage colony-stimulating factor. British Journal of Haematology 87(Suppl 1): 152
Knoflach, A.; Binswanger, U. 1992: Erythropoietin response and hippuric acid accumulation. Nephrology Dialysis Transplantation 7(7): 768
Besada, E.; Sanz Moreno, C.; Garrancho, J.M.; Sanchez, B.; Botella, J. 1994: Erythropoietin response in haemodialysis patients carriers of anti-hepatitis C antibodies. Nephrology Dialysis Transplantation 9(7): 1028
Aul, C.; Runde, V.; Arning, M.; Heyll, A.; Schneider, W. 1991: Erythropoietin response to anemia in 51 patients with myelodysplastic syndromes. Onkologie 14(Suppl 2): 6
Siciliano, M.; Tomasello, D.; Milani, A.; Rossi, L. 1994: Erythropoietin response to anemia in compensated and decompensated cirrhosis. Hepatology 20(4 Part 2): 399A
Brown, M.L.; Fields, S.D. 1992: Erythropoietin response to anemia in elderly nursing home residents with anemia of chronic disease of unexplained etiology. Journal of the American Geriatrics Society 40(10 Suppl): SA42
Powers J.S.; Krantz S.B.; Collins J.C.; Meurer K.; Failinger A.; Buchholz T.; Blank M.; Spivak J.L.; Hochberg M.; Baer A.; Et Al 1990: Erythropoietin response to anemia in the elderly. Clinical Research 38(1): 11A
Hager, S.; Gonzales, A.; Gonzales, M.; Winslow, R. 1996: Erythropoietin response to blood substitutes A model for tissue hypoxia. Blood 88(10 Suppl 1 Part 1-2): 184A
Hoff, K.I.; Zawada, E.T.; Alavi, F.K.; Leyse, J.W. 1994: Erythropoietin response to ketorolac tromethamine administration in rats. Journal of the American Society of Nephrology 5(3): 681
Munoz, S.J.; Caro, J.; Martin, P.; Westerberg, S.; Mortiz, M.; Jarrell, B.; Maddrey, W.C. 1990: Erythropoietin response to post liver transplant anemia. Hepatology 12(4 Part 2): 862
Hamilton, D.L.; Cotes, P.M. 1989: Erythropoietin responses to submandibular salivary gland manipulation. FASEB Journal 3(4): A994
Ireland, R.M.; Goldman, J.M.; Sullivan, C.E.; Bigg, J.C. 1990: Erythropoietin responses to transient hypoxia in humans. British Journal of Haematology 74(Suppl 1): 40
Watkins, P.J.; Winkler, A.S.; Marsden, J.; Chaudhuri, K.R. 1998: Erythropoietin responsive anaemia in diabetic autonomic neuropathy with and without nephropathy. Diabetologia 41(Suppl 1): A309
Sanders, M.R.; Walker, F.; Dainiak, N. 1992: Erythropoietin responsiveness and raf 1 mediated signal transduction in serum depleted cultures of human fetal neonatal and adult progenitor cells. Pediatric Research 31(4 Part 2): 270A
Carlini, R.; Rothstein, M. 1992: Erythropoietin rhuepo increases endothelin 1 et 1 in hemodialysis hd patients. Journal of the American Society of Nephrology 3(3): 424
Carlini, R.; Dusso, A.; Obialo, C.; Rothstein, M. 1992: Erythropoietin rhuepo increases endothelin 1 et 1 production and cell proliferation in bovine pulmonary arterial endothelial cells bpaec. Journal of the American Society of Nephrology 3(3): 423
Siciliano, M.; Tomasello, D.; Milani, A.; Ricerca, B.M.; Storti, S.; Rossi, L. 1995: Erythropoietin secretion in liver disease. Clinica Chimica Acta; International Journal of Clinical Chemistry 236(2): 217-218
Vreugdenhil G.; Schrey G.; Van Es P.N.; Teng H.T.; De Leeuw P.W. 1992: Erythropoietin secretion in relation to renal oxygen consumption and renin in patients with or without renal artery stenosis. European Journal of Clinical Investigation 22(4 Part 2): A26
Kokot, F.; Franek, E.; Kokot, M.; Wiecek, A. 1993: Erythropoietin secretion in uraemic patients after pure oxygen breathing. Nephrology Dialysis Transplantation 8(9): 959
Scherer, W.; Ruf, B.; Pohle, H.D. 1990: Erythropoietin serum levels in hiv infected patients with anemia and with without azt treatment. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb434
Blemings, K.P.; Eisenstein, R.S. 1998: Erythropoietin specific affects on iron regulatory protein 2 and targets of IRP action. FASEB Journal 12(5): A820
Lane, G.; Waite, N. 1994: Erythropoietin stability. Canadian Journal of Hospital Pharmacy 47(4): 182
Carroll, M.; Pless, M.; Mathey Prevot, B.; D'andrea, A.D. 1994: Erythropoietin stimulates erythroid differentiation by prolongation of the G1 phase of the cell cycle. Blood 84(10 Suppl 1): 365A
Bondurant, M.; Muta, K.; Yamashita, T.; Kelley, L.; Krantz, S.B.; Koury, M. 1993: Erythropoietin stimulates expression of c-myc without stimulating cell division in explanted mouse and human erythroblasts. Blood 82(10 Suppl 1): 226A
Westenbrink, B.Daan.; Oeseburg, H.; Kleijn, L.; van der Harst, P.; Belonje, A.M.S.; Voors, A.A.; Schoemaker, R.G.; de Boer, R.A.; van Veldhuisen, D.J.; van Gilst, W.H. 2008: Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. Cardiovascular Drugs and Therapy 22(4): 265-274
Westenfelder, C.; Biddle, D.L.; Baranowski, R.L. 1998: Erythropoietin stimulates proliferation of human and rat renal carcinoma cells in vitro. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 165A
Boissel, J.P.; Wen, D.; Showers, M.; Lee, W.R.; Bunn, H.F. 1993: Erythropoietin structure-function relationships Identification of functionally important domains. Blood 82(10 Suppl 1): 316A
Maxwell, P.; Lappin, T.; Macmanus, M. 1990: Erythropoietin synthesis localized to hypoxic renal tubular cells. Kidney International 37(1): 374
Goldwasser, E.; Beru, N.; Smith, D. 1991: Erythropoietin the primary regulator of red cell formation. Sporn, M B And A B Roberts (Ed ) Peptide Growth Factors And Their Receptors, I Xxviii+794p Springer-Verlag New York, Inc : New York, New York, Usa; Berlin, Germany Illus Paper 747-770
Goodnough, L.T.; Monk, T.G.; Andriole, G.L. 1997: Erythropoietin therapy. New England Journal of Medicine 336(13): 933-938
Markell, M.S.; Salifu, M.M.; Babinska, A.; Kornecki, E. 1997: Erythropoietin therapy affects response of platelets from uremic patients to stimulatory agonists. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 245A
Loibl, U.; Stockenhuber, F.; Manker, N.; Meisinger, V.; Meisl, F. 1990: Erythropoietin therapy and aluminum metabolism in hemodialysis patients. Nephrology Dialysis Transplantation 5(8): 741
Muntzel, M.; Hannedouche, T.; Lacour, B.; Drueke, T. 1991: Erythropoietin therapy and endogenous nitric oxide in normotensive and hypertensive rats. Journal of the American Society of Nephrology 2(3): 383
Koskimies, S.; Lautenschlager, I.; Grönhagen-Riska, C.; Häyry, P. 1990: Erythropoietin therapy and the antibody levels of highly sensitized patients awaiting kidney transplantation. Transplantation 50(4): 707-709
Ludwig, H.; Fritz, E.; Kotzmann, H.; Hoecker, P.; Gisslinger, H.; Barnas, U. 1990: Erythropoietin therapy for anemia of cancer. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 2
Henry, D.H. 1990: Erythropoietin therapy in AIDS. Progress in Clinical and Biological Research 338: 113-120
Goodnough, L.T. 1990: Erythropoietin therapy in autologous blood donors. Progress in Clinical and Biological Research 338: 105-112
Basile, C.; Montanaro, A.; Giordano, R.; Marangi, A.L.; De Padova, F.; Chiechi, G.; D'amelio, A.; Albano, R. 1993: Erythropoietin therapy in chronic uraemia Success of the intradermal route of administration. Nephrology Dialysis Transplantation 8(9): 955-956
A.K.arfy, T.; Smyth, J.; Fitzgerald, C.; Wadsworth, L.; Davis, J.; Krystal, G.; Milner, R. 1994: Erythropoietin therapy in infants predicted to require multiple transfusions. Pediatric Research 37(4 Part 2): 279A
Hartung, G.; Weigold, A.; Quarder, Q.; Oehl, S.; Essers, U.; Heim, M.E.; Fritze, D.; Baldus, M.; Hoelzer, D.; Bremer, K.; Queisser, W. 1993: Erythropoietin therapy in myelodysplastic syndromes A phase II study. Onkologie 16(Suppl 1): 21
Hoeldtke, R.D.; Streeten, D.H.P. 1992: Erythropoietin therapy in orthostatic hypotension. Clinical Research 40(2): 162A
Bjarnason, G.A.; Tobe, S.; Saiphoo, C.; Manuel, A.M.; Franssen, E.; Reis, M.C. 1997: Erythropoietin therapy in patients with chronic renal failure of hemodialysis A study of time-dependent activity. Blood 90(10 Suppl 1 Pt 2): 10B
Connelly, E.F.; Bukowski, R.A.; Hussein, M.A. 1995: Erythropoietin therapy in patients with myelodysplastic syndromes Response correlates with low erythropoietin levels. Blood 86(10 Suppl 1): 793A
Lacasse, M.S.; Lebel, M.; Lariviere, R.; Kingma, I.; Grose, J.H. 1997: Erythropoietin therapy increases endothelin-1 content in blood vessels of uremic rats. Clinical and Investigative Medicine 20(4 Suppl): S62
Kornowski, R.; Schwartz, D.; Jaffe, A.; Pines, A.; Aderka, D.; Levo, Y. 1992: Erythropoietin therapy obviates the need for recurrent transfusions in a patient with severe hemolysis due to prosthetic valves. Chest 102(1): 315-316
Shepherd, J.D.; Currie, C.J.; Sparling, T.G.; Krystal, G.; Eaves, A.C. 1992: Erythropoietin therapy of myelodysplastic syndromes. Blood 79(7): 1891-1892
Erslev, A.J. 1991: Erythropoietin titers in health and disease. Seminars in Hematology 28(3 Suppl 3: 2-7; Discussion: 7-8
Shigematsu, H.; Iwasaki, H.; Otsuka, T.; Ohno, Y.; Arima, E.; Niho, Y. 1995: Erythropoietin transduces proliferative signal through the formation of the VAV proto-oncogene product, erythropoietin receptor and phosphatidylinositol 3-kinase complex. Blood 86(10 Suppl 1): 150A
Kokot, F.; Wiecek, A.; Heidland, A.; Gilge, U.; Marcinkowski, W.; Rudka, R.; Trembecki, R. 1992: Erythropoietin treatment for 12 months does exert a marked inhibitory influence of plasma noradrenaline , adrenaline and dopamine concentrations in haemodialyzed patients with endstage renal failure. Nephrology Dialysis Transplantation 7(7): 768-769
Anderson, K.E.; Goeger, D.E.; Carson, R.W.; Lee, S.M.K.; Stead, R.B. 1990: Erythropoietin treatment for hemodialysis associated porphyria cutanea tarda. Molecular Aspects of Medicine 11(1-2): 73-74
Nair, B.; Leitch, J.; Black, A. 1996: Erythropoietin treatment for postural hypotension from autonomic dysfunction. Australian and New Zealand Journal of Medicine 26(6): 859-860
Bárány, P.; Pettersson, E.; Bergström, J. 1990: Erythropoietin treatment improves quality of life in hemodialysis patients. Scandinavian Journal of Urology and Nephrology. Supplementum 131: 55-60
Valenti, M.; Caramello, E.; Dionisio, P.; Cravero, R.; Salomone, M.; Peona, C.; Boccardo, G.P.; Piccoli, G.; Bajardi, P. 1994: Erythropoietin treatment in a large dialysis population. Nephrology Dialysis Transplantation 9(7): 1038
Mishra, S.; Tevlin, M.T.; Wang, Y.B.; Acchiardo, S.R.; Kang, E.S. 1998: Erythropoietin treatment in hemodialyzed patients is associated with increased asymmetric dimethylarginine concentrations. Journal of Investigative Medicine 46(1): 57A
Minetti, L. 1997: Erythropoietin treatment in renal anemia. how high should the target hematocrit be?. Journal of Nephrology 10(3): 117-119
Stenke, L.; Wallvik, J.; Hippe, E.; Bernell, P.; Grimfors, G.; Lofvenberg, E.; Hast, R. 1996: Erythropoietin treatment of MDS patients Who will benefit and for how long?. British Journal of Haematology 93(Suppl 2): 232-233
Molica, S. 1993: Erythropoietin treatment of anaemia associated with lymphoproliferative disorders. European Journal of Cancer 29a (10): 1499-1500
Cazzola, M.; Ponchio, L.; Rosti, V.; Liberato, N.L.; Bergamaschi, G.; Barosi, G.; Beguin, Y.; Ascari, E. 1991: Erythropoietin treatment of anemia associated with hematologic malignancies or hemopoietic stem cell disorders results of a phase i ii clinical trial. Experimental Hematology 19(6): 507
Qiao, Zhen Hua 1993: Erythropoietin treatment of anemia associated with multiple myeloma and myelodysplastic syndrome. Zhonghua Zhongliu Zazhi 15(2): 122-124
Ludwig, H.; Leitgeb, C.; Fritz, E.; Krainer, M.; Kührer, I.; Kornek, G.; Sagaster, P.; Weissmann, A. 1993: Erythropoietin treatment of chronic anaemia of cancer. European Journal of Cancer 29a Suppl 2: S8-12
Bechensteen, A.G.; Haga, P.; Grogaard, J.; Saugstad, O.D.; Halvorsen, S. 1992: Erythropoietin treatment of protein and iron supplemented premature AGA infants. Pediatric Research 32(5): 617
Rifkind, J.M.; Abugo, O.O.; Balagopalakrishna, C.; Spangler, E.; Ingram, D. 1994: Erythropoietin treatment of rats used to understand the changes in erythrocytes which occur during aging. Age 17(4): 171
Steinberg, M.H. 1991: Erythropoietin treatment of the anemia associated with renal functional impairment in sickle cell disease. Clinical Research 39(2): 268A
Brox, A.; Band, C.; Morin, B.; Gagnon, R.F. 1996: Erythropoietin treatment of the anemia of mice with chronic renal failure downregulates insulin-like growth factor binding protein 1. Journal of the American Society of Nephrology 7(9): 1628
Marson, P.; De Silvestro, G. 1995: Erythropoietin treatment of thrombocytopenia of chronic liver disease: need for more strictly-defined inclusion and evaluation criteria. Journal of Hepatology 23(2): 232
Mercuriali, F.; Inghilleri, G.; Biffi, E.; Colotti, M.T.; Vinci, A.; Scalamogna, R.; Zanella, A. 1994: Erythropoietin treatment to increase autologous blood donation in patients with low basal hematocrit undergoing elective orthopedic surgery. Clinical investigator 72(6 Suppl): S16-S18
Hrushesky, W.J.M.; Martynowicz, M.; Sanchez, D.L.R.na S.; Stratton, P.A. 1992: Erythropoietin tumor growth modulation. Proceedings of the American Association for Cancer Research 33: 269
Zhang, Z.; Barrett, J.D.; Zhu, J.H.; Lee, D.B.N.; Ward, H.J.; Jamgotchian, N.; Hu, M.S.; Eggena, P. 1996: Erythropoietin up regulates angiotensin receptors Further studies on the mechanism of RhEPO hypertension. Journal of the American Society of Nephrology 7(9): 1545
Li, R.; Sytkowski, A.J. 1997: Erythropoietin up-regulation of taxreb 107. Blood 90(10 Suppl 1 Pt 1): 47A
Weisz, K.; Kreiswirth, S.; Mcmeeking, M.; Braun, J.; Tirelli, J.; Talal, A.H.; Dieterich, D.T.; (Usa), H.R.source Network 1998: Erythropoietin use for ribavirin/interferon induced anemia in patients with hepatitis C. Hepatology 28(4 Part 2): 288A
Ellis, E.N.; Watts, K.; Wells, T.G.; Arnold, W.C. 1990: Erythropoietin use in pediatric dialysis patients. Clinical Research 38(4): 1000A
Vreugdenhil, G.; van Herpen, C.; Koene, R.A. 1993: Erythropoietin versus iron chelators in anaemia and iron overload. Netherlands Journal of Medicine 42(1-2): 45-47
Maier, R.F.; Obladen, M.; Kattner, E.; Natzschka, J.; Messer, J.; Moessinger, A.; Speer, C.P.; Fellman, V.; Grauel, E.L.; Groneck, P.; Wagner, M.; Moriette, G.; Salle, B.L.; Verellen, G.; Scigalla, P. 1997: Erythropoietin, 750 vs 1500 IU/kg/week in infants less than 1000 g. Pediatric Research 42(3): 399
Januszewicz, A.; Symonides, B.; Przybylski, J.; Januszewicz, M.; Lapinski, M.; Rowinski, O.; Pazdur, K.; Sinski, M.; Ziecina, R.; Kuczynska, K.; Wocial, B. 1993: Erythropoietin, endothelin-1 and neuropeptide Y renal venous blood plasma concentrations in patients with unilateral renal artery stenosis. European Heart Journal 14(ABST Suppl ): 240
Hu, R.H.; Lee, P.H.; Lee, C.J. 1996: Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril. Transplantation Proceedings 28(3): 1545-1547
Adamson, J. 1996: Erythropoietin, iron metabolism, and red blood cell production. Seminars in Hematology 33(2 Suppl 2: 5-7; Discussion: 8-9
Miller, K. 1998: Erythropoietin, with and without granulocyte-colony stimulating factor , in the treatment of myelodysplastic syndrome patients. Leukemia Research 22(Suppl 1): S13-S16
Paganini, E.P.; Hensen, H.; Green, R. 1993: Erythropoietin-associated red blood cell macrocytosis is not vitamin B-12 or folate dependent. Journal of the American Society of Nephrology 4(3): 429
Keller, G.; Beug, H.; Wagner, E. 1995: Erythropoietin-dependent erythroblastoid mouse cell line. Official Gazette of the United States Patent and Trademark Office Patents 1171(2): 1056
Kanfer, E.; Price, C.M.; Colman, S.M.; Barrett, A.J. 1992: Erythropoietin-independent colony growth in polycythaemia vera is not restricted to progenitor cells with trisomy of chromosome 8. British Journal of Haematology 82(4): 773-774
Brox, A.; Morin, B.; Katz, M. 1997: Erythropoietin-independent erythroid colony formation in two patients with polycythemia. Blood 90(10 Suppl 1 Pt 2): 11B
Oscier, D.G. 1994: Erythropoietin-independent erythroid progenitors in patients with sideroblastic anaemia and thrombocytosis. Leukemia Research 18(Suppl ): 37
Kirby, S.; Walton, W.; Smithies, O. 1998: Erythropoietin-induced competitive expansion of transplanted tepor transgenic hematopoietic stem cells in vivo. Experimental Hematology 26(8): 815
Ifudu, O.; Dawood, M.; Homel, P. 1998: Erythropoietin-induced elevation in blood pressure is immediate and dose dependent. Nephron 79(4): 486-487
Beccari, M. 1998: Erythropoietin-induced epilepsy in hemodialysis patients?. Nephron 78(3): 354
Tepel, M.; Neusser, M.; Heidenreich, S.; Rahn, K.H.; Zidek, W. 1992: Erythropoietin-induced hypertension is caused by direct vasopressor effects on renal resistance vessels and is mediated by increased cytosolic free calcium. Nephrology Dialysis Transplantation 7(7): 774
Tepel, M.; Wischniowski, H.; Schlueter, H.; Rahn, K.H.; Zidek, W. 1992: Erythropoietin-induced hypertension is mediated by transmembrane calcium influx. Biological Chemistry Hoppe-Seyler 373(9): 828-829
Gill, M.L.; Anderton, J.L. 1993: Erythropoietin-induced hypertension without raising haematocrit. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 8(11): 1264-1266
Lovcic, V.; Milutinovic, S.; Bubic, L.J.; Mazuran, R. 1997: Erythropoietin-induced immunoregulation in dialysis pts is independent on hemoglobin rise. Nephrology Dialysis Transplantation 12(9): A192
Ling, B.N.; Li, B.; Marrero, M.B. 1996: Erythropoietin-induced tyrosine phosphorylation stimulates phospholipase C-gamma-1 and Ca-2+ channels in glomerular mesangial cells. Journal of the American Society of Nephrology 7(9): 1681
Li, Y.; Sytkowski, A.J. 1993: Erythropoietin-induced upregulation of c-myc is mediated by protein kinase C epsilon. Blood 82(10 Suppl 1): 439A
Maxwell, P.H.; Osmond, M.K.; Pugh, C.W.; Heryet, A.; Nicholls, L.G.; Tan, C.C.; Doe, B.G.; Ferguson, D.J.; Johnson, M.H.; Ratcliffe, P.J. 1994: Erythropoietin-producing cells in transgenic mice expressing SV40 large T antigen directed by erythropoietin control sequences. Annals of the new York Academy of Sciences 718: 356-358
Mcgann, J.K.; Harbol, A.; Liesveld, J.; Palis, J. 1995: Erythropoietin-receptor signaling in murine yolk sac explants. Blood 86(10 Suppl 1): 151A
Tang, T.; Prasad, K.S.S.; Koury, M.J.; Brandt, S.J. 1997: Erythropoietin-stimulated phosphorylation of TAL1 involves mitogen-activated protein kinase. Blood 90(10 Suppl 1 Pt 1): 168A
Davis, K.L.; Sytkowski, A.J. 1995: Erythropoietins PKC epsilon pathway to c-myc regulates growth but not differentiation of erythroid cells. Experimental Hematology 23(8): 833
Sytkowski, A.J.; Lunn, E.D.; Lu, B.; Walsh, M.L. 1996: Erythropoietins polypeptide structure and folding are strongly influenced by differential glycosylation. Blood 88(10 Suppl 1 Part 1-2): 135B
Sytkowski, A.J.; Li, Y. 1994: Erythropoietins regulation of primary response genes via discrete signaling pathways. Abraham, N G , Shadduck, R K , Levine, A S , Takaku, F Molecular biology of haematopoiesis, Vol 3 163-167
Huang, S.; Negash, S.; Squier, T.C. 1998: Erythrosin isothiocyanate selectively labels lysine464 within the putative regulatory site of the Ca-ATPase in skeletal sarcoplasmic reticulum. Biophysical Journal 74(2 Part 2): A360
V.D.Tuuk Adriani, W.P.A.; Smit Sibinga, C.T. 1996: Erythrosol, a new preservation solution for erythrocytes. Vox Sanguinis 70(Suppl 2): 143
Stchepinsky, V. 1940: Erzincan mintakasinin ruesubi yataklari; gites sedimentaires de la region dErzincan. Pages 212-232 1940
Sagona, M.A.; Collinsworth, W.E.; Gadsden, R.H. 1992: Es 300 immunoassay system. Chan, D W (Ed ) Immunoassay Automation: A Practical Guide Xiv+367p Academic Press, Inc : San Diego, California, Usa; London, England, Uk Illus Paper 191-202
Anon 1989: Es 6864. Drugs of the Future 14(9): 852-854
Emonds, M.; Ruzicka, E.; Muckel, G.H.; Keller, R.; Mueller, U.; Baumann, H. 1991: Es hs from blood vessels a potent substance for inert nonthrombogenic polymers. Clinical Materials 8(1-2): 47-56
Kondoh, H. 1990: Es mediated transfer of the chicken delta crystallin gene into the mouse authentic versus ectopic expression. Acta Histochemica et Cytochemica 23(5): 712
Bessler, M.; Rosti, V.; Tremml, G.; Soares, V.; Pandolfi, P.P.; Luzzatto, L. 1996: Es-cells with an inactivating mutation in the pig-a gene contribute to hematopoiesis in chimeric mice and differentiate to red cells and lymphocytes with the PNH phenotype. British Journal of Haematology 93(Suppl 2): 44
Burts, M.L.; DeDent, A.C.; Missiakas, D.M. 2008: EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. Molecular Microbiology 69(3): 736-746
Smiley, B.L.; Scholler, J.K.; Stuart, K. 1989: Esag1 genes in trypanosoma brucei a comparison of genomic and complementary dna clones. Journal of Cellular Biochemistry Suppl (13 Part E): 121
Naiyanetr, P.; Ng, P.K.L. 1997: Esanpotamon namsom, a new genus and species of potamid crab from a waterfall in northeastern Thailand. Proceedings of the Biological Society of Washington 110(3): 417-421
Massa, P.; Michetti, P.; Coccia, G.; Civardi, R.; Dodero, M. 1990: Esaprazole in the treatment of reflex esophagitis. Gastroenterology 98(5 Part 2): A85
Ratner, B.D.; Castner, D.G. 1990: Esca analysis. Biomaterials 11(2): 143-145
Morais, H.; Caramori, P.-Henrique; Koguishi, M.-Sei; De-Arruda-Ribeiro, A.-Maria 2008: Escala fenologica detalhada da fase reprodutiva de Coffea arabica. Bragantia 67(1): 257-260
Logothetis, C.; Sella, A.; Amato, R.; Kilbourn, R.; Ellerhorst, J.; Zukiwski, A. 1993: Escalated MVAC plus or minus/rhGM-CSF in patients with advanced metastatic transitional cell carcinoma of the bladder. Journal of Urology 149(4 Suppl): 318A
Bokemeyer C.; Harstrick A.; Schoeffski P.; Illiger H J.; Metzner B.; Ruether U.; Ostermann H.; Hohnloser J.; Clemm C.; Berdel W.; Et Al 1991: Escalated cisplatinum c etoposide e and ifosfamide i plus gm csf in high risk testis cancer. Onkologie 14(Suppl 2): 18
Cain, J.; Collons, C.; Ellis, G.; Tamimi, H. 1991: Escalated dose chemotherapy for ovarian cancer without autologous bone marrow support. Gynecologic Oncology 40(2): 177-178
Logothetis, C.J.; Finn, L.; Dexeus, F.H.; Sella, A.; Amato, R.J.; Kilbourn, R.G.; Gutterman, J. 1990: Escalated mvac plus rhgm csf recombinant human glycosylated granulocyte macrophage colony stimulating factor schering plough sandoz in chemotherapy refractory advanced urothelial tumors. Journal of Urology 143(4 Suppl): 291A
Gasparini, G.; Fior, S.D.; Panizzoni, G.A.; Favretto, S.; Pozza, F. 1990: Escalating dose mitoxantrone in combination with alpha 2 interferon in patients with resistant advanced solid tumors phase i study. Anticancer Research 10(5 Part B): 1426-1427
Schlaifer, D.; Attal, M.; Huguet, F.; Canal, P.; Laurent, G.; Pris, J. 1994: Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantation. Seminars in Hematology 31(2 Suppl 3: 31
Rose, S.; Hindmarsh, J.G.; Collins, P.; Campbell, D.B.; Jenner, P. 1993: Escalating doses of fenfluramine prevent the long-lasting 5-hydroxytryptamine depletion in the rat. Society for Neuroscience Abstracts 19(1-3): 1893
Rosell, R.; Gómez-Codina, J.; Anton, A.; Sánchez, J.J.; Vadell, C. 1994: Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate. Seminars in Oncology 21(1 Suppl 1: 48-53
Saposnik, G.; Fang, J.; O'Donnell, M.; Hachinski, V.; Kapral, M.K.; Hill, M.D. 2008: Escalating levels of access to in-hospital care and stroke mortality. Stroke 39(9): 2522-2530
Petty, B.; Black, J.; Hendrix, C.; Bassiakos, Y.; Feinberg, J.; Hafner, R. 1993: Escalating multiple-dose safety and tolerance of WR 6026 in HIV-infected subjects. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 498
Li, B.H.; Rowland, N.E. 1994: Escalating or repeated doses of dexfenfluramine Effect on fos induced in brain by DF and other anorectics. Society for Neuroscience Abstracts 20(1-2): 588
Bonomi, P.; Siddiqui, S.; Lincoln, S.; Sharma, M.; Recine, D.; Warren, W.; Faber, L.P. 1996: Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage IIi non-small cell lung cancer. Seminars in Oncology 23(6 Suppl 16: 102-107
Gray, J.E.; Peterman, V.C.; Zuckerman, J.E. 1992: Escalating single dose pharmacokinetics of DuP 734, a novel sigma antagonist, in young healthy subjects. Pharmaceutical Research (New York) 9(10 Suppl): S307
Ward, P.; Cox, S.R.; Staton, B.A.; Harry, J.D.; Oliver, S.; Keedy, F.; Potuszynskyj, A. 1992: Escalating single dose safety tolerance and pharmacokinetics of u 87201e in healthy male volunteers. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b92
Sterling, R.K.; Post, A.B.; Murphy, M.B.; Hoffman, R.D.; Jacbos, G.H. 1997: Escalating the dose of interferon does not increase the incidence of virologic response in patients with chronic hepatitis C. Gastroenterology 112(4 Suppl): A1389
Sterling, R.K.; Post, A.B.; Murphy, M.B.; Hoffman, R.D.; Jacobs, G.H. 1997: Escalating the dose of interferon fails to eradicate virus in chronic hepatitis C patients with normal aminotransferases. Gastroenterology 112(4 Suppl): A1389
Cassileth P.A.; Andersen J.W.; Bennett J.; Harrington D.P.; Hines J.D.; Lazarus H.M.; Mazza J.J.; Mcglave P.P.; O'connell M.J.; Et Al 1992: Escalating the intensity of postremission therapy improves the outcome in acute myeloid leukemia the ecog experience. Leukemia 6(Suppl 2): 116-119
Sher, G.D.; Colwill, R.; Couture, F.; Crump, M.; Keating, A. 1993: Escalating the melphalan dose in a regimen including high dose etoposide for autologous bone marrow transplantation is not associated with enhanced toxicity. Clinical and Investigative Medicine 16(4 Suppl): B64
Malin, A.S.; McAdam, K.P. 1995: Escalating threat from tuberculosis: the third epidemic. Thorax 50(Suppl 1): S37-S42
Fennelly, D.; Schneider, J.; Bengala, C.; Barakat, R.; Curtin, J.; Jones, W.; Spriggs, J.L.J.L.wis D.; Hoskins, W.; Norton, L. 1995: Escalating-dose Taxol plus high-dose cyclophosphamide plus G-CSF followed by rapidly sequences courses of HD carboplatin plus C rescued with peripheral blood progenitor cells in patients with stage IIC-IV ovarian cancer. Gynecologic Oncology 56(1): 121
Tesch, H.; Lathan, B.; Rueffer, U.; Sieber, M.; Engert, A.; Franklin, J.; Hasenclever, D.; Pfreundschuh, M.; Koch, P.; Adler, M.; Mueller, U.; Schalk, P.; Doelken, G.; Worst, P.; Boissevain, F.; Diehl, V. 1996: Escalation of dose intensity for advanced stage Hodgkins disease using the beacopp scheme - Studies of the German Hodgkin study group. Blood 88(10 Suppl 1 Part 1-2): 673A
Gillis, M.; Surette, C.; Richard, D.; Watson Wright, W. 1991: Escalation of paralytic shellfish poison in viscera of georges bank scallops placopecten magellanicus from 1988 to 1990. Canadian Technical Report of Fisheries and Aquatic Sciences 1799: 9-10
Bauman, R.; Kant, G. 1992: Escapable and inescapable shock disrupt delayed alternation in rats. Society for Neuroscience Abstracts 18(1-2): 351
Kita, E. 1995: Escape mechanism of Neisseria gonorrhoeae and disseminated gonococcal infection. Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 50(2): 481-490
Bovee, E.C. 1996: Escape attempts by Euglena spirogyra captured by Amoeba proteus. Journal of Eukaryotic Microbiology 43(1): 9A
Blazquez, M.C.; Rodriguez Estrella, R.; Delibes, M. 1997: Escape behavior and predation risk of mainland and island spinytailed iguanas. Ethology 103(12): 990-998
Douglass, A.D.; Kraves, S.; Deisseroth, K.; Schier, A.F.; Engert, F. 2008: Escape behavior elicited by single, channelrhodopsin-2-evoked spikes in zebrafish somatosensory neurons. Current Biology: Cb 18(15): 1133-1137
Kurtz, S.; Flinn, J.; Holt, R.; Weber, J.; Allen, K. 1989: Escape behavior in juvenile aplysia is affected by protein and tryptophan deficient diet. Society for Neuroscience Abstracts 15(2): 1139
Godzinska, E.J.; Korczynska, J.; Szczuka, A.; Kieruzel, M.; Burnat, K. 1997: Escape behaviour of bumblebees as a system of responses to cues of various modalities. Taborsky, M, Taborsky, B Advances in Ethology; Contributions to the XXV International Ethological Conference: 104
Robertson, K.D.; Manns, A.; Swinnen, L.J.; Hayward, S.D.; Ambinder, R.F. 1995: Escape from Epstein-Barr virus -specific cytotoxic T cell immune surveillance in neoplastic and non-neoplastic B cells is facilitated by methylation of a crucial site in the major viral latency promoter. Blood 86(10 Suppl 1): 740A
Portnoy, D.A. 1994: Escape from a vacuole and cell-to-cell spread of Listeria monocytogenes. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 37
Zietara, M.S.; Kuusela, J.; Lumme, J. 2006: Escape from an evolutionary dead end: a triploid clone of Gyrodactylus salaris is able to revert to sex and switch host (Platyhelminthes, Monogenea, Gyrodactylidae). Hereditas 143(2006): 84-90
Gerbino, W.; Bruno, N. 1994: Escape from capture in translational motion. IOVS Investigative Ophthalmology and Visual Science 35(4): 1271
Bird, A.G.; Gore, S.M.; Leigh-Brown, A.J.; Carter, D.C. 1991: Escape from collective denial: HIV transmission during surgery. Bmj 303(6798): 351-352
Hoelting, T.; Siperstein, A.E.; Clark, O.H.; Duh, Q.Y. 1994: Escape from growth factor control in metastatic follicular thyroid cancer Effects of thyrotropin , other growth factors and serum depletion on invasion of a primary and two metastatic follicular thyroid cancer cell lines. Proceedings of the American Association for Cancer Research 35: 163
Pawelec, G.; Zeuthen, J.; Kiessling, R. 1997: Escape from host-antitumor immunity. Critical Reviews in Oncogenesis 8(2-3): 111-141
Mcmichael, A.; Goulder, P.; Rowland Jones, S.; Phillips, R.; Xu, X.; Screaton, G. 1997: Escape from immune control by HIV. FASEB Journal 11(9): A1003
Mentz, F.; Ruscetti, F.W.; Debre, P.; Mossalayi, M.D. 1995: Escape from inhibitory effect of transforming growth factor-beta of IL-7 proliferation pathway in acute T cell lymphoblastic leukemia and Sezary lymphoma Possible mechanism for T cell malignancies. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY The 9th International Congress of Immunology : 509
Sakaida, I.; Hironaka, K.; Uchida, K.; Kubo, Y.; Kayano, K.; Okita, K. 1998: Escape from inhibitory growth regulation by TGF-beta1 in preneoplastic lesions in rat liver. Hepatology 28(4 Part 2): 601A
Knight, R.T.; Grabowecky, M. 1995: Escape from linear time Prefrontal cortex and conscious experience. Gazzaniga, M S The cognitive neurosciences 1357-1371
Butler, T.D.; Rinehart, C.A.; Kaufman, D.G. 1990: Escape from senescence crisis by sv 40 transformed human endometrial stromal cells results in increased anchorage independent growth. Proceedings of the American Association for Cancer Research 31: 108
Bond, J.A.; Wyllie, F.S.; Wynford-Thomas, D. 1994: Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9(7): 1885-1889
Littlefield, J.W. 1996: Escape from senescence in human keratinocyte cultures. Experimental Gerontology 31(1-2): 29-32
Guarneri, E.M.; Sklar, M.A.; Russo, R.J.; Claire, D.; Schatz, R.A.; Teirstein, P.S. 1995: Escape from stent jail An in vitro model. Circulation 92(8): I688
Shiigai, T.; Owada, A.; Ujiie, K.; Tomura, S.; Shichiri, M. 1998: Escape from the antiproteinuric effect of angiotensin-converting enzyme inhibitor in nondiabetic nephropathy. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 80A
S.M.; Norris, K.A.; Seifert, H.S. 1990: Escape from the host humoral response examples from two microbial pathogens. Van Der Ploeg, L H T , C R Cantor And H J Vogel (Ed ) Immune Recognition And Evasion: Molecular Aspects Of Host-Parasite Interaction; P And S Biomedical Sciences Symposium, New York, New York, Usa, June 3-5, 1988 Xiii+315p Academic Press, Inc : San Diego, California, Usa; London, England, Uk Illus 175-182
Toma, J.G.; Miller, F.D. 1991: Escape from translational degradation the neuronal growth associated alpha tubulin mrna t alpha 1 is preferentially stabilized in pc12 cells. Society for Neuroscience Abstracts 17(1-2): 380
Mitsuyama, M. 1997: Escape mechanism of Listeria monocytogenes in relation to host immune response. Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 52(3): 593-600
Takeuchi, S.; Kera, J.; Inoko, H. 1991: Escape mechanism of the placenta from immunologic rejection with special emphasis on novel mhc antigens on trophoblast. Soma, H (Ed ) Placenta: Basic Research For Clinical Application; International Conference on Placenta, Tokyo, Japan, October 1-3, 1990 Vii+213p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 154-165
Guertler, L. 1994: Escape mechanisms of HIV from the immune surveillance. Periodicum Biologorum 96(3): 255
Heinz, B.A.; Shepard, D.A.; Rueckert, R.R. 1990: Escape mutant analysis of a drug binding site can be used to map functions in the rhinovirus capsid. Laver, W G And G M Air (Ed ) Use Of X-Ray Crystallography in The Design Of Antiviral Agents; International Workshop, Kona, Hawaii, Usa, February 6-8, 1989 Xxxiv+360p Academic Press, Inc : Troy, Missouri, Usa; London, England, Uk Illus 173-186
Siebelink, K.H.J.; Rimmelzwaan, G.F.; Huisman, R.C.; Bosch, M.L.; Osterhaus, A.D.M.E. 1992: Escape mutants of molecularly cloned feline immunodeficiency virus used for the identification of a neutralizing determinant. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : a74
Mukai, M.; Takasu, H. 1993: Escape of Litsea citriodora to the Sennan district. Acta Phytotaxonomica et Geobotanica 44(1): 82-85
Aylor, D.E. 1997: Escape of Venturia inaequalis ascospores from a ground cover canopy. Phytopathology 87(6 Suppl): S5
Vinuela, E. 1990: Escape of african swine fever virus from the immune system. AIDS Research and Human Retroviruses 6(11): 1355
Rudnicka, W.; Wadstrom, T.; Chmiela, M. 1997: Escape of cellular defense mechanisms by Helicobacter pylori. Immunology 92(Suppl 1): 39
Isaksen, B.; Lokkeborg, S. 1993: Escape of cod and haddock from Danish seine codends during fishing and surface hauling operations. ICES Marine Science Symposia 196: 86-91
Roth, R.; Beglinger, C. 1991: Escape of diarrhea inhibition during consecutive treatment courses with octreotide and alpha interferon in 2 vipoma patients. Digestion 49(1): 50
Huso, D.L.; Narayan, O. 1990: Escape of lentiviruses from immune surveillance. Kurstak, E Et Al (Ed ) Applied Virology Research, Vol 2 Virus Variability, Epidemiology, And Control Xvii+368p Plenum Publishing Corporation: New York, New York, Usa; London, England, Uk Illus Maps 61-74
De Rosa, G.; Testa, A.; Giacomini, D.; Carrozza, C. 1994: Escape phenomenon after successful bromocriptine and octreotide treatment in thyroid stimulating hormone secreting pituitary adenoma residual tissue. European Journal of Cancer 30a (2): 247-248
Rubinstein, A.; Weintraub, M. 1995: Escape phenomenon of low-density lipoprotein cholesterol during lovastatin treatment. American Journal of Cardiology 76(3): 184-186
Husain, M.; Freedman, J.J.; Hegele, R.A. 1991: Escape phenomenon of lpa in sustained plasma exchange. Clinical Research 39(3): 666A
Lardy, G.P.; Klopfenstein, T.J.; Adams, D.C.; Clark, R.T.; Mass, R.A.; Lamb, J.B. 1996: Escape protein content of meadow and native range in the Nebraska sandhills. Journal of Animal Science 74(Suppl 1): 284
Van Koevering, M.T.; Gill, D.R.; Owens, F.N.; Mccollum, F.T. 1991: Escape protein for shipping stressed calves. Journal of Animal Science 69(Suppl 1): 157
Kirch, B.H.; Moser, L.E.; Waller, S.S.; Klopfenstein, T.J. 1994: Escape protein of cool- and warm-season grasses utilized by grazing cattle. Journal of Dairy Science 77(Suppl 1): 114
Sindt, M.R.S.; Klopfenstein, T. 1991: Escape protein sources for finishing calves and yearlings. Journal of Animal Science 69(Suppl 1): 158
Ramos, J.A.; Mendoza, G.D.; Aranda, E.; Garcia Bojalil, C.; Barcena, R.; Alanis, J. 1995: Escape protein supplementation of growing steers grazing star grass. Journal of Animal Science 73(Suppl 1): 272
Nelson, M.L.; Martin, E.L. 1996: Escape protein supplementation of steers consuming barley finishing diets. Journal of Animal Science 74(Suppl 1): 278
Klopfenstein, T.J.; Gutierrez Ornelas, E. 1989: Escape protein supplementation of steers grazing cornstalks. Journal of Dairy Science 72(Suppl 1): 495
Nelson, M.L.; Duncan, R.W. 1994: Escape protein supplementation of steers grazing irrigated pasture with animal by-products. Journal of Dairy Science 77(Suppl 1): 276
Hollingsworth Jenkins, K.J.; Klopfenstein, T.J.; Adams, D.C.; Lamb, J.B. 1994: Escape protein, rumen degradable protein, or energy as the first limiting nutrient of fall-born nursing calves. Journal of Dairy Science 77(Suppl 1): 359
Katzir, G.; Camhi, J.M. 1993: Escape response of black mollies to predatory dives of a pied kingfisher. Copeia 2: 549-553
Skold, M. 1998: Escape responses in four epibenthic brittle stars. Ophelia 49(3): 163-179
Meager, J.J.; Domenici, P.; Shingles, A.; Utne-Palm, A.C. 2006: Escape responses in juvenile Atlantic cod Gadus morhua L.: the effects of turbidity and predator speed. Journal of Experimental Biology 209(Part 20): 4174-4184
Anderson, R.C.; Mather, J.A. 1996: Escape responses of Euprymna scolopes Berry, 1911. Journal of Molluscan Studies 62(4): 543-545
Newland, P.L.; Neil, D.M. 1991: Escape swimming in the norway lobster. Journal of the Marine Biological Association of the United Kingdom 71(3): 718
Spanier, E.; Weihs, D. 1990: Escape swimming of the mediterranean slipper lobster scyllarides latus behavioral and hydrodynamic aspects. American Zoologist 30(4): 122A
Serlin, B.S.; Lew, R.R.; Schauf, C.L.; Sumida, K.D. 1990: Escape time of two phytochrome regulated events in mougeotia potassium ion channel activity and chloroplast rotation. Plant Physiology 93(1 Suppl): 89
Jorstad,K.E.; Meeren,T.vander; Paulsen,O.I.; Thomsen,T.; Thorsen,A.; Svasand,T. 2008: Escapes of eggs from farmed cod spawning in net pens recruitment to wild stocks. Reviews In Fisheries Science: 1 3, 285-295
Verbelen, J P.; Quelo, A.H.; Olyslaegers, G. 1998: Escaping from control Unconventional cell cycles. Journal of Experimental Botany 49(Suppl ): 91
Willemse, P.H.B.; Dikkeschei, L.D.; Wolthers, B.G.; De Ruyter Buitenhuis, A.W.; Nagel, G.T. 1994: Escaping oestrogen blockade The effect of aromatase inhibitors on levels of delta-5-androstenediol, oestrone, oestradiol and their sulphates in serum of postmenopausal breast cancer patients. European Journal of Endocrinology 130(Suppl 2): 258
Orozco, J.; Perez, M. 2008: Escarabajos coprofagos Coleoptera, Scarabaeoidea del Parque Nacional Los Estoraques Norte de Santander, Colombia. Revista Brasileira de Entomologia 52(1): 36-40
Hung, V.C.; Mines, J.S. 1991: Eschars and scarring from hot needle acupuncture treatment. Journal of the American Academy of Dermatology 24(1): 148-149
Walters, W.P.; Dolata, D.P.; Yalkowsky, S.H. 1994: Escher A computer program for the determination of external rotational symmetry numbers from molecular topology. Pharmaceutical Research (New York) 11(10 Suppl): S117
Olmstead, L.C.; Petras, R.E.; Griffin, P.M. 1989: Escherichia coli 0157 h7 associated colitis a histologic study of 10 cases. Laboratory Investigation 60(1): 68A
Neill, M.A. 1990: Escherichia coli 0157 h7 current concepts and future prospects. Journal of Food Safety 10(2): 99-106
Potter, M. 1989: Escherichia coli 0157 h7 defining a new pathogen. Journal of the American Veterinary Medical Association 194(12): 1788
Wasteson, Y. 1997: Escherichia coli 0157H7 Again. Norsk Veterinaertidsskrift 109(2): 107
Toth, I.; Csik, M.; Patthy, A.; Ruzsics, Z.; Czirok, E.; Nagy, B.; Janosi, L. 1998: Escherichia coli 0157H7 FliC flagellar region is a hypermutable locus. Abstracts of the General Meeting of the American Society for Microbiology 98: 232
Brandt, J.; Fouser, L.; Watkins, S.; Zelikovic, I.; Avner, E. 1993: Escherichia coli 0157H7 associated hemolytic uremic syndrome following ingestion of contaminated hamburgers. Journal of the American Society of Nephrology 4(3): 313
Buhk, T.; Albrecht, H.; Stellbrink, H.J. 1994: Escherichia coli 0157H7-associated hemolytic uremic syndrome and HIV. AIDS-Forschung 9(11): 614
Götz, F.; Dabbs, E.R.; Gualerzi, C.O. 1990: Escherichia coli 30S mutants lacking protein S20 are defective in translation initiation. Biochimica et Biophysica Acta 1050(1-3): 93-97
Futai, M.; Iwamoto, A.; Omote, H.; Orita, Y.; Shin, K.; Nakamoto, R.K.; Maeda, M. 1992: Escherichia coli ATP synthase Catalytic site and regulation of proton translocation. Journal of Experimental Biology 172: 443-449
A.S.awi, M.K.; Nakamoto, R.K. 1995: Escherichia coli ATP synthase gamma subunit uncoupling mutation, Met-23 to Lys, disrupts its interactions with epsilon subunit and destabilizes the F-1 complex. FASEB Journal 9(6): A1357
Ruiz, L.Alberto.; Zalacain, R.; Gómez, A.; Camino, Jús.; Jaca, C.; Núñez, J.Manuel. 2008: Escherichia coli: an unknown and infrequent cause of community acquired pneumonia. Scandinavian Journal of Infectious Diseases 40(5): 424-427
Nakamoto, R.K.; Shin, K.; Iwamoto, A.; Omote, H.; Maeda, M.; Futai, M. 1992: Escherichia coli F0F1-ATPase. Residues involved in catalysis and coupling. Annals of the new York Academy of Sciences 671: 335-343; Discussion: 343-344
Bianchi, M.E.; Beltrame, M.; Pontiggia, A. 1993: Escherichia coli HU protein is the functional analog of mammalian HMG1 protein. Journal of Cellular Biochemistry Suppl 1993(17 Part E): 288
Bhattacharjee, A.; Taylor, R.; Collins, H.; Opal, S.; Cross, A.; Zollinger, W.; Sadoff, J. 1994: Escherichia coli J5 LPS as non-covalent complex vaccine with Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative bacteremia. Abstracts of the General Meeting of the American Society for Microbiology 94: 151
Mayer, A.M.S.; Oh, S.; Lamar, P.; Prozialeck, W.C.; Ramsey, K.H.; Jacobson, P.; Glaser, K.B.; Romanic, A. 1998: Escherichia coli LPS-induced apoptosis in rat brain neonatal microglia. Society for Neuroscience Abstracts 24(1-2): 1753
Leif, H.; Weidner, U.; Berger, A.; Spehr, V.; Braun, M.; van Heek, P.; Friedrich, T.; Ohnishi, T.; Weiss, H. 1993: Escherichia coli NADH dehydrogenase I, a minimal form of the mitochondrial complex i. Biochemical Society Transactions 21(4): 998-1001
Vital, M.; Hammes, F.; Egli, T. 2008: Escherichia coli O157 can grow in natural freshwater at low carbon concentrations. Environmental Microbiology 10(9): 2387-2396
Gross, R.J. 1992: Escherichia coli O157-a food-borne pathogen?. Medical Laboratory Sciences 49(3): 202-203
Kwiatek, K.; Rozanska, H. 1996: Escherichia coli O157H7 Etiological agent of food transmitted intoxications in humans A review. Medycyna Weterynaryjna 52(1): 29-32
Oporto,B.; Esteban,J.I.; Aduriz,G.; Juste,R.A.; Hurtado,A. 2008: Escherichia coli O157H7 and non-O157 Shiga toxin-producing E coli in healthy cattle, sheep and swine herds in Northern Spain. Zoonoses And Public Health: 2, 73-81
Cristancho,L.; Johnson,R.P.; McEwen,S.A.; Gyles,C.L. 2008: Escherichia coli O157H7 and other Shiga toxin-producing E coli in white veal calves. Veterinary Microbiology 6: 1 3, 200-209
Griffin, P.M. 1995: Escherichia coli O157H7 and other enterohemorrhagic Escherichia coli. Blaser, M J , Smith, P D , Ravdin, J I , Greenberg, H/ B , Guerrant, R L Infections of the gastrointestinal tract 739-761
Boyce, T.G.; Swerdlow, D.L.; Griffin, P.M. 1995: Escherichia coli O157:H7 and the hemolytic-uremic syndrome. New England Journal of Medicine 333(6): 364-368
McNeilly, T.N.; Naylor, S.W.; Mahajan, A.; Mitchell, M.C.; McAteer, S.; Deane, D.; Smith, D.G.E.; Low, J.Christopher.; Gally, D.L.; Huntley, J.F. 2008: Escherichia coli O157:H7 colonization in cattle following systemic and mucosal immunization with purified H7 flagellin. Infection and Immunity 76(6): 2594-2602
Griffin, P.M.; Ries, A.A.; Greene, K.D.; (Usa), T.E.cherichia Coli O157:h7 Study Group 1993: Escherichia coli O157H7 diarrhea in the United States A multicenter surveillance project. Journal of Food Protection 56(10): 906
Tarr, P.I.; Bilge, S.S.; Besser, T.E.; Vary, J.C.Jr 1998: Escherichia coli O157H7 epithelial adhesin. Official Gazette of the United States Patent and Trademark Office Patents 1213(4): 3703
Arkin,R. 2008: Escherichia coli O157H7 foodborne illness and the usefulness of the critical path in FDAs work to combat it. Fda Veterinarian: 1, 9-12
Ojo,O.E.; Oyekunle,M.A.; Ogunleye,A.O.; Otesile,E.B. 2008: Escherichia coli O157H7 in food animals in parts of south-western Nigeria prevalence and in vitro antimicrobial susceptibility. Tropical Veterinarian: 3 4, 23-30
Naito, M.; Ishii, K.; Nakamura, Y.; Kobayashi, M.; Takada, S.; Koike, K. 1997: Simple method for efficient production of hepatitis B virus core antigen in Escherichia coli. Research in Virology 148(4): 299-305
Anonymous 2008: Escherichia coli O157H7 infections in children associated with raw milk and raw colostrum from cows - California, 2006. Morbidity And Mortality Weekly Report: 23, 625-628
Bilge, S.S.; Vary, J.C.; Potter, K.; Dowell, S.F.; Tarr, P.I. 1995: Escherichia coli O157H7 lipopolysaccharide mutants are hyperadherent. Abstracts of the General Meeting of the American Society for Microbiology 95: 166
Minter, J.; Richardson, S.C.; Degraves, F.J.; Wright, J.C.; Penfound, T.; Foster, J.W.; Price, S.B. 1998: Escherichia coli O157H7 shedding from experimentally inoculated calves. Abstracts of the General Meeting of the American Society for Microbiology 98: 83-84
Poirier, K.; Faucher, S.éb.P.; Béland, M.; Brousseau, R.; Gannon, V.; Martin, C.; Harel, J.ée.; Daigle, F. 2008: Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infection and Immunity 76(11): 4814-4822
Wachsmuth, I.K.; Griffin, P.M.; Wells, J.G. 1991: Escherichia coli O157:H7, a cause of hemorrhagic colitis and hemolytic uremic syndrome. Acta Paediatrica Japonica: Overseas Edition 33(5): 603-612
Tang, H.; Kim, Y.; Severinov, K.; Goldfarb, A.; Ebright, R.H. 1996: Escherichia coli RNA polymerase holoenzyme: rapid reconstitution from recombinant alpha, beta, beta', and sigma subunits. Methods in Enzymology 273: 130-134
Van Houten, B.; Snowden, A. 1993: Escherichia coli UvrABC nuclease system A recognition enzyme with broad specificity. Environmental and Molecular Mutagenesis 21(Suppl 22): 74
Singh, R.; Britton, R.S.; Epperly, N.A.; Tredway, T.L.; Bacon, B.R.; Matuschak, G.M. 1993: Escherichia coli acutely upregulates procollagen I gene expression in isolated perfused rat liver. Hepatology 18(4 Part 2): 170A
Johnson, J.R.; Nowicki, B.J.; Skubitz, K.M. 1991: Escherichia coli adhesins that recognize the dr blood group antigen mediate adherence to neutrophils. Clinical Research 39(3): 726A
Lobo, A.B.; Sagar, P.M.; Rothwell, J.; Riches, T.; Johnston, D.; Axon, A.T.R. 1991: Escherichia coli adhesion is not related to acute pouchitis. Gut 32(10): A1219
Nesmeyanova, M.; Karamyshev, A.; Kalinin, A.; Tsfasman, I.; Badyakina, A.; Khmelnitsky, M.; Shlyapnikov, M.; Ksenzenko, V. 1994: Escherichia coli alkaline phosphatase biogenesis Influence of overproduction and amino acid substitutions. Torriani-Gorini, A , Yagil, E , Silver, S Phosphate in microorganisms: Cellular and molecular biology 264-269
Koenig, B.; Koenig, W. 1991: Escherichia coli alpha hemolysin and adhesions their role in cytokine release and in cytokine specific m rna expression. Immunobiology 183(3-4): 350
Foster, P.L. 1992: Escherichia coli and Salmonella typhimurium, mutagenesis. Lederberg, J Encyclopedia of Microbiology, Vols 1-4: 4) 107-114
Findlay, G.; Hirst, T.R. 1994: Escherichia coli and Vibrio cholerae strains deficient in an enzyme involved in disulphide bond formation show an increase in sensitivity to dithiothreitol. Biochemical Society Transactions 22(1): 77S
Sussman, M. 1997: Escherichia coli and human disease. Sussman, M Escherichia coli: Mechanisms of virulence: 3-48
Sedlock, D.M.; Coughlin, S.A.; Rake, J.B. 1989: Escherichia coli and micrococcus luteus gyrase inhibition of quinolones compared and examined as a function of cellular minimum inhibitory concentration mic. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 23
Guerrant, R.L. 1990: Escherichia coli and related enteric pathogens. Warren, K S And A A F Mahmoud Tropical And Geographical Medicine, Second Edition Xx+1159p Mcgraw-Hill, Inc : New York, New York, Usa; Auckland, New Zealand Illus Maps 776-790
Dlabac, V.; Tlaskalova, H. 1991: Escherichia coli and salmonella typhimurium as a model for complement recognition. Clinical and Experimental Immunology 86(Suppl 1): 8
Zalay, L.; Runow, K.D.; Szatloczky, E. 1992: Escherichia coli antibodies in chronic inflammatory bowel disease New ways of diagnosis and immunotherapy. Verdauungskrankheiten 10(5): 180-185
Fijalkowska, I.; Schaaper, R.M. 1992: Escherichia coli antimutator mutants in the alpha subunit of dna polymerase iii. Journal of Cellular Biochemistry Suppl (16 Part B): 83
Wernicki, A.; Rzedzicki, J. 1992: Escherichia coli as an etiological agents of digestive diseases in calves. Medycyna Weterynaryjna 48(9): 396-399
Hayashi, H.; Inoue, Y.; Kuramitsu, S.; Kagamiyama, H. 1991: Escherichia coli aspartate aminotransferase effects of site specific mutations on substrate binding and catalysis. Fukui, T , Et Al (Ed ) International Union Of Biochemistry Symposium, 199 Enzymes Dependent on Pyridoxal Phosphate And Other Carbonyl Compounds As Cofactors; 8th International Symposium on Vitamin B6 And Carbonyl Catalysis, Osaka, Japan, October 15-19, 1990 Xviii+656p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 183-186
Long, D.G.; Weis, R.M. 1992: Escherichia coli aspartate receptor. Oligomerization of the cytoplasmic fragment. Biophysical Journal 62(1): 69-71
Allewell, N.M. 1989: Escherichia coli aspartate transcarbamoylase: structure, energetics, and catalytic and regulatory mechanisms. Annual Review of Biophysics and Biophysical Chemistry 18: 71-92
Kantrowitz, E.R.; Lipscomb, W.N. 1990: Escherichia coli aspartate transcarbamoylase: the molecular basis for a concerted allosteric transition. Trends in Biochemical Sciences 15(2): 53-59
Dalmau, D.; Navarro, F.; Mirelis, B.; Blanco, J.; Garau, J.; Prats, G. 1996: Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen. Journal of Hospital Infection 34(3): 233-234
Longuet, P.; Lortholary, O.; Benoit, C.; Leport, C.; Vilde, J.L.uis 1995: Escherichia coli bacteraemia and cellulitis in AIDS 2 case reports. Annales de Medecine Interne 146(7): 521
Bloom, I.T.; Bentley, F.R.; Garrison, R.N. 1993: Escherichia coli bacteremia exacerbates cyclosporine-induced renal vasoconstriction. Journal of Surgical Research 54(5): 510-516
Van Roekel, D.; Clark, P. 1994: Escherichia coli bacterin for the reduction of clinical signs of toxic mastitis in cattle. Bovine Practitioner 1994(28): 50-55
Savilahti, H.; Caldentey, J.; Pakula, T.M.; Bamford, D.H. 1992: Escherichia coli bacteriophage prd1 protein primed dna replication with purified proteins. Journal of Cellular Biochemistry Suppl (16 Part B): 53
Ng, B.; Polyak, S.W.; Bird, D.; Bailey, L.; Wallace, J.C.; Booker, G.W. 2008: Escherichia coli biotin protein ligase: characterization and development of a high-throughput assay. Analytical Biochemistry 376(1): 131-136
Soriano, G.; Such, J.; Guarner, C.; Coll, P.; Prats, G.; Vilardell, F. 1993: Escherichia coli capsular polysaccharide and prognosis in spontaneous bacterial peritonitis. Gastroenterology 104(4 Suppl): A998
Soriano, G.; Such, J.; Guarner, C.; Coll, P.; Prats, G.; Vilardell, F. 1993: Escherichia coli capsular polysaccharide in spontaneous bacterial peritonitis. Journal of Hepatology 18(Suppl 1): S173
Castanet, J.; Lacour, J.P.; Perrin, C.; Bodokh, I.; Dor, J.F.; Ortonne, J.P. 1992: Escherichia coli cellulitis: two cases. Acta Dermato-Venereologica 72(4): 310-311
Tabona, P.; Nair, S.; Reddi, K.; Miller, A.; Preuss, M.; Henderson, B. 1997: Escherichia coli chaperonin 60 stimulates pro-inflammatory cytokine synthesis in a conformation-independent manner. Journal of Medical Microbiology 46(12): 1055
Miller, A.D.; Maghlaoui, K.; Albanese, G.; Kleinjan, D.A.; Smith, C. 1993: Escherichia coli chaperonins Cpn60 and Cpn10 do not catalyse the refolding of mitochondrial malate dehydrogenase. Biochemical Journal 291(1): 139-144
Bornemann, S.; Lowe, D.J.; Thorneley, R.N. 1996: Escherichia coli chorismate synthase. Biochemical Society Transactions 24(1): 84-88
Bornemann, S.; Ramjee, M.K.; Balasubramanian, S.; Abell, C.; Coggins, J.R.; Lowe, D.J.; Thorneley, R.N.F. 1995: Escherichia coli chorismate synthase catalyzes the conversion of -6-fluoro-5-enolpyruvylshikimate-3-phosphate to 6-fluorochorismate Implications for the enzyme mechanism and the antimicrobial action of -6-fluoroshikimate. Journal of Biological Chemistry 270(39): 22811-22815
Park, K.H.; Kim, I.C.; Kim, K.H.; Cha, J.H.; Jang, S.Y.; Kim, J.R.; Seo, B.C.; Choi, Y.D. 1996: Escherichia coli containing a gene encoding a maltogenic amylase BLMA of Bacillus licheniformis and gene product produced by same. Official Gazette of the United States Patent and Trademark Office Patents 1193(2): 1245
Romeo, T. 1997: Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1204(1): 509-510
Huelsmann K H.; Bergerat Coulaud, A.; Hahn, U. 1990: Escherichia coli dam activity in herpes buffer asks for a new unit definition. Nucleic Acids Research 18(23): 7189
Singh, B.; Atwal, O.S. 1994: Escherichia coli derived lipopolysaccharides mobilize the globular surface coat of pulmonary intravascular macrophages of sheep. FASEB Journal 8(4-5): A149
Armarego, W.L.F.; Vasudevan, S.C. 1990: Escherichia coli dihydropteridine reductase is a trifunctional enzyme with dihydrofolate reductase activity. Curtius, H -C , S Ghisla And N Blau (Ed ) Chemistry And Biology Of Pteridines, 1989: Pteridines And Folic Acid Derivatives; Ninth International Symposium on Pteridines And Folic Acid Derivatives Chemical, Biological, And Clinical Aspects, Zurich, Switzerland, September 3-8, 1989 Xxxv+1340p Walter De Gruyter And Co : Berlin, West Germany; Hawthorne, New York, Usa Illus 616-619
Koonin, E.V. 1993: Escherichia coli dinG gene encodes a putative DNA helicase related to a group of eukaryotic helicases including Rad3 protein. Nucleic Acids Research 21(6): 1497
Nataro, J.P.; Levine, M.M. 1994: Escherichia coli diseases in humans. Gyles, C L Escherichia coli in domestic animals and humans 285-333
Bonner, C.A.; Randall, S.K.; Mcentee, K.; Goodman, M.F. 1989: Escherichia coli dna polymerase ii characterization of an sos inducible polymerase capable of insertion and bypass at abasic lesions in dna. Journal of Cellular Biochemistry Suppl (13 Part D): 118
Spengler, M.; Sawyer, R.; Adams, R.; Groschel, D.; Pruett, T. 1990: Escherichia coli ec peritonitis the differential recovery of strains in the presence of hemoglobin. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 43
Romero, M.J.; Canada, A.T. 1990: Escherichia coli effect of oxidant stress on growth lethality and glutathione concentrations. FASEB Journal 4(7): A2164
Miller, E.M.; Nickoloff, J.A. 1995: Escherichia coli electrotransformation. Methods in Molecular Biology 47: 105-113
Mark, I.R.; Westlake, W.; Montgomery, B.S.; Tiptaft, R.C.; Pambakian, H. 1995: Escherichia coli endophthalmitis: a rare presentation of renal parenchymal malakoplakia. British Journal of Urology 76(3): 401-402
Hoff, R.G.; Wheelan, S.; Popovsky, M.A. 1991: Escherichia coli endotoxemia resulting from a platelet transfusion. Transfusion 31(8 Suppl): 35S
Stanley, E.; Stead, R.; Collins, S.M. 1992: Escherichia coli endotoxin exerts a biphasic effect on acetylcholine release from rat myenteric plexus. Gastroenterology 102(2 Part 2): A700
Campbell, E.; Cury, J.; Welgus, H. 1989: Escherichia coli endotoxin is a major regulator of procollagenase gelatinase and stromelysin secretion by human alveolar macrophages. Chest 95(3 Suppl): 204S-205S
Koyama, S.; Rennard, S.I.; Rickard, K.; Robbins, R.A. 1989: Escherichia coli endotoxin stimulates the release of neutrophil chemotactic activity from and causes cytotoxicity to bovine bronchial epithelial cells in vitro. American Review of Respiratory Disease 139(4 Part 2): A371
Ammerlaan, M.C.; Earhart, C.F. 1992: Escherichia coli enterobactin synthetase need not be a membrane bound multi enzyme complex. Abstracts of the General Meeting of the American Society for Microbiology 92: 275
Simon, D.; Rest, R.F. 1992: Escherichia coli expressing a neisseria gonorrhoeae opa protein invade cultured human epithelial cells. Abstracts of the General Meeting of the American Society for Microbiology 92: 42
Guerreiro, C.I.P.D.; Fontes, C.M.G.A.; Gama, M.; Domingues, L.íl. 2008: Escherichia coli expression and purification of four antimicrobial peptides fused to a family 3 carbohydrate-binding module (CBM) from Clostridium thermocellum. Protein Expression and Purification 59(1): 161-168
Flint, N.A.; Amrein, K.E.; Gassmann, M.; Burn, P. 1992: Escherichia coli expression purification and characterization of the protein tyrosine kinase p56l c k. Experientia 48(ABSTR): A16
Poole, R.K.; Rogers, N.J.; D'mello, R.A.M.; Hughes, M.N.; Orii, Y. 1997: Escherichia coli flavohaemoglobin reduces cytochrome c and Fe -hydroxamate K by electron transfer from NADH via FAD Sensitivity of oxidoreductase activity to haem-bound dioxygen. Microbiology (Reading) 143(5): 1557-1565
Lobo, A.J.; Hawkey, P.M.; Sagar, P.M.; Axon, A.T.R. 1992: Escherichia coli from patient with inflammatory bowel disease ibd lack genes for enterotoxin production. Gastroenterology 102(4 Part 2): A655
Flint, D.H.; Mckay, R.G. 1994: Escherichia coli fumarase A catalyzed transfer of 18O from C-2 and 2H from C-3 of malate to acetylene dicarboxylate to form 18O and 2H labeled oxalacetate. Journal of the American Chemical Society 116(13): 5534-5539
Siegele, D.A. 1993: Escherichia coli functions required for resuming growth after starvation. Journal of Cellular Biochemistry Suppl 1993(17 Part E): 282
Kobayashi, D.; Stayton, M.; Keen, M. 1991: Escherichia coli galu mutant blocks avirulence gene d elicitor production in culture. Phytopathology 81(10): 1187
Clementz, T.; Bednarski, J.; Raetz, C.R.H. 1995: Escherichia coli genes encoding KDO dependent acyltransferases that incorporate laurate and myristate into lipid A. FASEB Journal 9(6): A1311
Rather, P.N.; Baca Delancey, R.R.; Thomas, M.M.; Ding, X. 1998: Escherichia coli genes regulated by quorum sensing. Abstracts of the General Meeting of the American Society for Microbiology 98: 284
Gardiol, A.; Preiss, J. 1989: Escherichia coli glutamic acid 39 adp glucose synthetase has different activation kinetics from the wild type allosteric enzyme. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 209
Chattoraj, D.; Sozhamannan, S.; Mukhopadhyay, G.; Papp, P. 1992: Escherichia coli heat shock proteins dnaj and dnak help p1 plasmid replication by stimulating initiator binding to the origin. Journal of Cellular Biochemistry Suppl (16 Part B): 42
Mcroberts, J.A.; Riley, N.; Forte, L.R. 1992: Escherichia coli heat stable enterotoxin mediates chloride secretion through cgmp and protein kinase a. Gastroenterology 102(4 Part 2): A226
Goldstein, J.L.; Bhuva, M.B.; Layden, T.J.; Rao, M.C. 1991: Escherichia coli heat stable enterotoxin stimulated chloride secretion is abnormal in cystic fibrosis rectal mucosa in vivo. Clinical Research 39(2): 363A
Lin, M.; Guggino, S. 1992: Escherichia coli heat stable toxin induces chloride currents in t84 cells. Gastroenterology 102(4 Part 2): A221
Marcello, A.; Palu, G.; Hirst, T.R. 1992: Escherichia coli heat-labile enterotoxin B subunit as a carrier for delivery of a peptide with anti-HSV activity. Biochemical Society Transactions 20(4): 311S
Harville, B.A.; Howard, D.E.; Shaban, R.; Beatty, D.M.; Morris, S.J.; Dreyfus, L.A. 1993: Escherichia coli heat-stable enterotoxin B elevates. Abstracts of the General Meeting of the American Society for Microbiology 93: 73
Harville, B.A.; Dreyfus, L.A.; Morris, S.J. 1993: Escherichia coli heat-stable enterotoxin B opens a G-protein operated calcium channel in the plasma membrane of treated cells. Molecular Biology of the Cell 4(Suppl ): 238A
Chao, K.L.; Dreyfus, L.A. 1998: Escherichia coli heat-stable enterotoxin B promotes leakage and fusion of lipid vesicles. Abstracts of the General Meeting of the American Society for Microbiology 98: 100
Eaglestone, S.; Ruddock, L.; Hirst, T.R. 1996: Escherichia coli heat-stable enterotoxin STa Oxidation in vitro and the role of DsbA. Zentralblatt fuer Bakteriologie Suppl 28: 341-342
Hirayama, T.; Wada, A. 1996: Escherichia coli heat-stable enterotoxin and its receptor interaction. Zentralblatt fuer Bakteriologie Suppl 28: 86-96
Giannella, R.A. 1995: Escherichia coli heat-stable enterotoxins, guanylins, and their receptors: what are they and what do they do?. Journal of Laboratory and Clinical Medicine 125(2): 173-181
Suttorp, N.; Fuhrmann, M.; Tannert Otto, S.; Bhakdi, S. 1992: Escherichia coli hemolysin and staphylococcus aureus alpha toxin induced nitric oxide synthesis in cultured porcine pulmonary artery endothelial cells. American Review of Respiratory Disease 145(4 Part 2): A835
Grimminger, F.; Sibelius, U.; Bhakdi, S.; Suttorp, N.; Seeger, W. 1991: Escherichia coli hemolysin is a potent inductor of the phosphoinositide hydrolysis related signal transduction pathway. American Review of Respiratory Disease 143(4 Part 2): A680
Hofmann, K.H.; Schweder, T. 1993: Escherichia coli host/plasmid systems providing biological containment. Woehrmann, K, Tomiuk, J Advances in Life Sciences; Transgenic organisms: Risk assessment of deliberate release: 193-208
Pham, T.; Martens, M.; Hart, A.; Nowicki, B. 1993: Escherichia coli human choriogonadotropin hormone-like peptides Partial characterization and association with acute pyelonephritis. Abstracts of the General Meeting of the American Society for Microbiology 93: 56
Wray, C.; Woodward, M.J. 1991: Escherichia coli in animal disease current developments. Journal of Applied Bacteriology 71(6)
Evans, D.J.Jr; Evans, D.G. 1991: Escherichia coli in diarrheal disease. Baron, S (Ed ) Medical Microbiology, Third Edition Xx+1340p Churchill Livingstone: New York, New York, Usa; London, England, Uk Illus 367-375
Brown, J.M.; Proum, S.; Sobsey, M.D. 2008: Escherichia coli in household drinking water and diarrheal disease risk: evidence from Cambodia. Water Science and Technology: a Journal of the International Association on Water Pollution Research 58(4): 757-763
Fairbrother,J.M. 2008: Escherichia coli in pig farming 3 Diagnostic strategies. Suis: , 44-54
Ishii, S.; Sadowsky, M.J. 2008: Escherichia coli in the Environment: Implications for Water Quality and Human Health. Microbes and Environments 23(2): 101-108
Bettelheim, K.A. 1997: Escherichia coli in the normal flora of humans and animals. Sussman, M Escherichia coli: Mechanisms of virulence: 85-109
Hamilton Miller, J.M.T. 1991: Escherichia coli in urinary tract infections. Journal of Applied Bacteriology 71(6)
Karlsson, A.; Markfjall, M.; Stromberg, N.; Dahlgren, C. 1995: Escherichia coli induced activation of the neutrophil NADPH-oxidase. European Journal of Clinical Investigation 25(Suppl 2): A25
Stoltz, D.A.; Bagby, G.J.; Nelson, S. 1998: Escherichia coli induced plasma granulocyte colony-stimulating factor response is suppressed by ethanol. Journal of Investigative Medicine 46(1): 56A
Bortolussi, R. 1990: Escherichia coli infection in neonates: humoral defense mechanisms. Seminars in Perinatology 14(4 Suppl 1: 40-43
Steinrueck, H.; Bindemann, U. 1989: Escherichia coli infections in east germany. Zeitschrift fuer Klinische Medizin 44(14): 1185-1188
Wray, C.; Woodward, M.J. 1997: Escherichia coli infections in farm animals. Sussman, M Escherichia coli: Mechanisms of virulence: 49-84
Peeters, J.E. 1994: Escherichia coli infections in rabbits, cats, dogs, goats and horses. Gyles, C L Escherichia coli in domestic animals and humans 261-283
Taylor, K.; Wegrzyn, G.; Wegrzyn, A.; Szalewska Palasz, A.; Herman, A.; Obuchowski, M.; Srutkowska, S.; Konopa, G. 1997: Escherichia coli initiator protein DnaA, cell-cycle and control of lambda plasmid replication. Bulletin of the Polish Academy of Sciences Biological Sciences 44(3-4): 225-230
Miura, K.; Ueno, S.; Katsumi, K.; Chinzei, Y. 1994: Escherichia coli injection results in selective induction of novel genes in Riptortus clavatus. Zoological Science 11(Suppl ): 38
Zhu, Y.; Magnusson, U.; Fossum, C.; Berg, M. 2008: Escherichia coli inoculation of porcine mammary glands affects local mRNA expression of Toll-like receptors and regulatory cytokines. Veterinary Immunology and Immunopathology 125(1-2): 182-189
Goodman, S.D.; Nash, H.A. 1992: Escherichia coli integration host factor ihf can be replaced by heterologous bends in excision of bacteriophage lambda. Biophysical Journal 61(2 Part 2): A139
Sussman, J.K.; Simons, E.L. 1990: Escherichia coli integration host factor represses the is10 transposase promoter. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 159
Eaves-Pyles,T.; Allen,C.A.; Taormina,J.; Swidsinski,A.; Tutt,C.B.; Jezek,G.E.; Islas-Islas,M.; Torres,A.G. 2008: Escherichia coli isolated from a Crohns disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. International Journal of Medical Microbiology 8: 5 6, 397-409
Rocque, W.J.; Mcgroarty, E.J. 1989: Escherichia coli k 12 wild type ompc porin dimer isolation and preliminary characterization. Biophysical Journal 55(2 Part 2): 320A
Artz P.; Rastinejad F.; Lu P. 1992: Escherichia coli lac repressor amino terminal dna binding fragment complex with fluorine 19 labelled operator for nmr observation. Biophysical Journal 61(2 Part 2): A282
Ludwig, K.; Karmali, M.A.; Muller Wiefel, D.E. 1996: Escherichia coli lipopolysaccharide and verotoxin 2 antibody response in children with enteropathic haemolytic uremic syndrome. Pediatric Nephrology 10(4): C109
Bautista, A.P.; Arruebarrena, E.; Roy, S.; Shoichet, A. 1998: Escherichia coli lipopolysaccharide clearance during alcohol intoxication. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 109A
Hull, S. 1997: Escherichia coli lipopolysaccharide in pathogenesis and virulence. Sussman, M Escherichia coli: Mechanisms of virulence: 145-167
Sugiyama, J.; Mahmoodian, S.; Jacobson, G. 1991: Escherichia coli mannitol permease alkaline phosphatase fusions constructed by a nested deletion method prediction of six transmembrane regions in the permease protein. FASEB Journal 5(5): A1191
Rafferty J.B.; Somers W.S.; Phillips K.; Boys C.W.G.; Manfield I.; He Y.; Rushton B.; Mcnally T.; Saint Girons I.; Et Al 1992: Escherichia coli met repressor a new dna binding motif. Sarma, R H And M H Sarma (Ed ) Structure And Function, Vol 2 Proteins; Seventh Conversation in The Discipline Biomolecular Stereodynamics, Albany, New York, Usa, June 18-22, 1991 X+192p Adenine Press: Schenectady, New York, Usa Illus 55-59
Rafferty J.B.; Somers W.S.; Phillips K.; Boys C.W.G.; Manfield I.; Hu Y.; Rushton B.; Mcnally T.; Saint Girons I.; Et Al 1991: Escherichia coli methionine repressor a new dna binding motif. Journal of Biomolecular Structure and Dynamics 8(6): A272
Cheng, X.; Wang, W.; Molineux, I.J.; Cheng, X.; Molineux, I.J. 1998: Escherichia coli mutants affecting F exclusion of T7. Abstracts of the General Meeting of the American Society for Microbiology 98: 364
Byerly, K.; Stauffer, G.V. 1989: Escherichia coli mutants that produce a met r activator protein with an altered homocysteine response. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 179
Lea, E.J.A.; Lakey, J.H. 1992: Escherichia coli ompc porin channels exhibit fast transitions. Biophysical Journal 61(2 Part 2): A515
Herlong, J.R.; Ware, R.E.; Kinney, T.R. 1990: Escherichia coli osteomyelitis of the metacarpal bone in a child with sickle cell disease. Pediatric Infectious Disease Journal 9(2): 144-146
Genden, E.M.; Goebel, J.A. 1998: Escherichia coli osteomyelitis of the skull base. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 118(6): 853-855
Dho Moulin, Maryvonne 1993: Escherichia coli pathogenic for poultry. Annales de Medecine Veterinaire 137(5): 353-357
Scarpace, P.J.; Bender, B.S.; Borst, S.E. 1990: Escherichia coli peritonitis in rats increases gdp binding in brown adipose tissue relationship to fever. FASEB Journal 4(3): A784
Likhacheva, N.A.; Sineokiĭ, S.P. 1989: Escherichia coli phage receptors. Minor porins and proteins participating in the specific transport as phage receptors. Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 12: 3-12
Roth, M.R.; Welti, R. 1990: Escherichia coli phosphatidylethanolamine nearest neighbors can be determined by chemical cross linking. Biophysical Journal 57(2 Part 2): 486A
Lea, E.J.A.; Bishop, N.D.; Lakey, J.H. 1993: Escherichia coli porin channels, fast transitions and voltage dependence. Biophysical Journal 64(2 Part 2): A94
Mitchell, L.W.; Jaffe, E.K. 1992: Escherichia coli porphobilinogen synthase is a zinc ii metalloenzyme. Biophysical Journal 61(2 Part 2): A459
Jezewska, M.; Rajendran, S.; Bujalowski, W. 1998: Escherichia coli primary replicative helicase DnaB protein - DNA complex Recognition and structure. Biophysical Journal 74(2 Part 2): A70
Bujalowski, W.; Kim, U.S.; Jezewska, M.J. 1995: Escherichia coli primary replicative helicase DnaB protein Oligomeric structure and interactions with ssDNA. Biophysical Journal 68(2 Part 2): A296
Plückthun, A. 1994: Escherichia coli producing recombinant antibodies. Bioprocess Technology 19: 233-252
Demeler, B.; Zhou, G. 1991: Escherichia coli promoter prediction using a neural network. Biophysical Journal 59(2 Part 2): 166A
Hertz, G.Z.; Stormo, G.D. 1996: Escherichia coli promoter sequences: analysis and prediction. Methods in Enzymology 273: 30-42
Smulski, D.R.; Vollmer, A.C.; Van Dyk, T.K.; Belkin, S.; Larossa, R.A. 1994: Escherichia coli promoter-lux fusions responsive to nutritional deprivation. FASEB Journal 8(7): A1311
Sahin, A.; Stravodimos, K.G.; Goldfischer, E.R.; Smith, A.D.; Singhal, P.C. 1998: Escherichia coli promotes macrophage apoptosis A new marker of virulence. Journal of Urology 159(5 Suppl): 274
Starkova, N.; Melnikov, E.; Rasulova, F.; Ginodman, L.; Rotanova, T. 1997: Escherichia coli protease Lon Role of domains in enzyme functioning. FASEB Journal 11(9): A861
Cronan, J.E.Jr 1989: Escherichia coli pyruvate oxidase an enzyme that shuttles between membrane and cytosol. Journal of Cellular Biochemistry Suppl (13 Part E): 257
Chang, Y.Y.; Wang, A.Y.; Cronan, J.E.Jr 1993: Escherichia coli pyruvate oxidase gene expression is controlled by the Sigma factor rpoS. Abstracts of the General Meeting of the American Society for Microbiology 93: 220
Hopf, U.; Moller, B.; Stemerowicz, R.; Lobeck, H.; Rodloff, A.; Freudenberg, M.; Galanos, C.; Huhn, D. 1990: Escherichia coli r rough mutants in the gut and lipid a in the liver of patients with primary biliary cirrhosis. EOS-Rivista di Immunologia ed Immunofarmacologia 10(4): 168-169
Bianchi, M.E. 1992: Escherichia coli reca protein requires atp hydrolysis to incorporate mismatches into heteroduplex dna. Journal of Cellular Biochemistry Suppl (16 Part B): 34
Wick, K.L.; Matthews, K.S. 1989: Escherichia coli repressor proteins. Adolph, K W (Ed ) Molecular Biology Of Chromosome Function Xiii+431p Springer-Verlag: New York, New York, Usa; Berlin, West Germany Illus 133-156
Muller-Serieys, C.; Laussucq, C.; Andremont, A. 2008: Escherichia coli resistant aux beta-lactamines etude de l effet bactericide des penicilliones associees aux nhibiteurs de beta-lactamases. Antibiotiques 10(1): 50-58
Platt, T.; Richardson, J.P. 1992: Escherichia coli rho factor Protein and enzyme of transcription termination. McKnight, S L , Yamamoto, K R Cold Spring Harbor Monograph Series; Transcriptional regulation 365-388
David, C.L.; Keener, J.; Aswad, D.W. 1997: Escherichia coli ribosomal protein S11 is a major substrate for protein L-isoaspartyl methyltransferase. FASEB Journal 11(9): A1275
Bowser, C.; Hanna, M. 1990: Escherichia coli rna polymerase contacts with the 3 end of rna in a transcription initiation complex. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 193
Woody A Y.M. 1990: Escherichia coli rna polymerase has a specific binding site for the 3 hydroxyl terminal 33 base rna. Journal of Cellular Biochemistry Suppl (14 Part B): 149
Tanaka, T.; Arakawa, Y.; Ohsuka, S.; Horii, T.; Ohta, M. 1995: Escherichia coli robA gene is involved in multiple antibiotic resistance. Abstracts of the General Meeting of the American Society for Microbiology 95: 160
Hopf, U.; Moeller, B.; Stemerowicz, R.; Rodloff, A.; Lobeck, H.; Freudenberg, M.; Galanos, C. 1989: Escherichia coli rough r mutants in the gut and lipid a in the liver from patients with primary biliary cirrhosis pbc. Journal of Hepatology 9(Suppl 1): S42
Kudo, T. 1994: Escherichia coli secretion vector using the kil gene. Bioprocess Technology 19: 291-299
Kay, M.A.; McCabe, E.D. 1990: Escherichia coli sepsis and prolonged hypophosphatemia following exertional heat stroke. Pediatrics 86(2): 307-309
Barzaga, R.A.; Nowak, P.A.; Cunha, B.A. 1991: Escherichia coli septic arthritis of a shoulder in a diabetic patient. Heart and Lung: the Journal of Critical Care 20(6): 692-693
Gay, C.C.; Besser, T.E. 1994: Escherichia coli septicaemia in calves. Gyles, C L Escherichia coli in domestic animals and humans 75-90
Park, J.W. 1991: Escherichia coli septicemia associated with acute appendicitis. Southern Medical Journal 84(5): 667-668
Feng, P. 1995: Escherichia coli serotype O157:H7: novel vehicles of infection and emergence of phenotypic variants. Emerging Infectious Diseases 1(2): 47-52
Monteiro Neto, V.; Campos, L.C.; Gomes, T.A.T.; Ferreira, A.J.P.; Trabulsi, L.R. 1996: Escherichia coli serotypes O111H12, O111H10, and O111H4 represent a distinct and potentially enteropathogenic clone. Abstracts of the General Meeting of the American Society for Microbiology 96: 253
Donnison,A.; Ross,C.; Clark,D. 2008: Escherichia coli shedding by dairy cows. New Zealand Journal Of Agricultural Research: 3, 273-278
Lingwood C.A.; Tyrrell G.; Ramotar K.; De Grandis S.; Brunton J.; Gyles C. 1989: Escherichia coli shiga like toxin ii variant slt iiv specifically binds to globotetraosylceramide. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 44
Wang, P.; Shim, E.; Cravatt, B.; Jacobsen, R.; Schoeniger, J.; Kim, A.C.; Paetzel, M.; Dalbey, R.E. 2008: Escherichia coli signal peptide peptidase a is a serine-lysine protease with a lysine recruited to the nonconserved amino-terminal domain in the S49 protease family. Biochemistry 47(24): 6361-6369
Lohman, T.M.; Bujalowski, W. 1990: Escherichia coli single strand binding protein multiple single stranded dna binding modes and cooperativities. Revzin, A (Ed ) The Biology Of Nonspecific Dna-Protein Interactions Vii+261p Crc Press, Inc : Boca Raton, Florida, Usa Illus 131-170
Mostafavi, M.R.; Stein, P.C.; Parsons, C.L.well 1994: Escherichia coli soluble virulence factor. Journal of Urology 151(5 Suppl): 407A
Kim, J.H.; Auger, E.; Soly, R.; Matin, A. 1993: Escherichia coli starvation genes Cloning and analysis of pex. Abstracts of the General Meeting of the American Society for Microbiology 93: 249
Shea, K.W.; Cunha, B.A. 1995: Escherichia coli sternal osteomyelitis after open heart surgery. Heart and Lung: the Journal of Critical Care 24(2): 177-178
Wilson, R.A.; Whittam, T.; Kapur, V. 1997: Escherichia coli strain 364 and use of said strain as a vaccine. Official Gazette of the United States Patent and Trademark Office Patents 1199(4): 2574
Michail, S.; Wei, S.; Mack, D.R. 1997: Escherichia coli strain E2348/69 in vitro adhesion is reduced in the presence of a Lactobacillus species. Gastroenterology 112(4 Suppl): A1042
Cantey, J.R.; Moseley, S.L. 1998: Escherichia coli strain RDEC-1 pilus mediated adherence to intestinal and Peyers patch epithelium requires an adhesin distinct from the major structural subunit. Abstracts of the General Meeting of the American Society for Microbiology 98: 109
Romero, M.J.; Imlay, J.A.; Canada, A.T. 1990: Escherichia coli strains and oxidant stress differences in growth lethality and gsh. Free Radical Biology and Medicine 9(Suppl 1): 20
Moyenuddin, M.; Wachsmuth, I.K.; Moseley, S.L.; Bopp, C.A.; Blake, P.A. 1989: Escherichia coli strains isolated during outbreaks of diarrheal illness in children in the usa. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 37
Moreira, F.C.; Vieira, Mônica.A.M.; Ferreira, A.J.P.; Girão, D.M.; Vaz, Tânia.M.I.; Rosa, A.Cláudia.P.; Knobl, T.; Irino, K.; Freymüller, E.; Gomes, Tânia.A.T. 2008: Escherichia coli strains of serotype O51:H40 comprise typical and atypical enteropathogenic E. coli strains and are potentially diarrheagenic. Journal of Clinical Microbiology 46(4): 1462-1465
Broes, A. 1993: Escherichia coli strains pathogenic for dogs and cats. Annales de Medecine Veterinaire 137(5): 377-384
Yan, G.; Judge, B.A.; Eaton, J.W.; Mahoney, J.R. 1997: Escherichia coli strains with iron-dependent virulence evade host clearance. Pediatric Research 41(4 Part 2): 133A
Condon, C.; Squires, C.; Squires, C. 1993: Escherichia coli strains with multiple ribosomal RNA operons inactivated have increased expression of the remaining intact copies. Abstracts of the General Meeting of the American Society for Microbiology 93: 236
Caldelari, I.; Palmer, T.; Sargent, F. 2008: Escherichia coli tat mutant strains are able to transport maltose in the absence of an active malE gene. Archives of Microbiology 189(6): 597-604
Gorby, G.; Simon, D.; Rest, R.F. 1994: Escherichia coli that express Neisseria gonorrhoeae opacity-associated proteins attach to and invade human fallopian tube epithelium. Annals of the new York Academy of Sciences 730: 286-289
Hanson, C.A.; Jacobson, B.A.; Fuchs, J.A.; Woodward, C. 1991: Escherichia coli thioredoxin mutant k57g the effect of k57 on the redox mechanism. Biophysical Journal 59(2 Part 2): 484A
Hiasa, H.; Digate, R.J.; Marians, K.J. 1993: Escherichia coli topoisomerase III, but not topoisomerase I, can segregate daughter DNA molecules during oriC and pBR322 DNA replication in vitro. Journal of Cellular Biochemistry Suppl 1993(17 Part E): 294
Rasquinha, I.; Hogue, C.W.V.; Szabo, A.G.; Macmanus, J.P. 1992: Escherichia coli tryptophan trna synthetase will incorporate 5 hydroxytryptophan into expressed proteins a new intrinsic fluorescent probe. Biophysical Journal 61(2 Part 2): A453
Orndorff, P.E. 1994: Escherichia coli type 1 pili. Miller, V L, Kaper, J B, Portnoy, D A, Isberg, R R Molecular genetics of bacterial pathogenesis: A tribute to Stanley Falkow 91-111
Bennett, S.E.; Sanderson, R.; Jensen, O.N.; Barofsky, D.F.; Mosbaugh, D.W. 1995: Escherichia coli uracil-DNA glycosylase binding and interaction with DNA. Journal of Cellular Biochemistry Suppl 1995(21A): 288
Beck, D.E.; O'donovan, G.A. 1995: Escherichia coli uridine kinase expression in Pseudomonas. Abstracts of the General Meeting of the American Society for Microbiology 95: 545
Hopkins, W.J.; Rowher Nutter, P.; Morin, M.D.; Uehling, D.T. 1998: Escherichia coli urinary tract infections in mice deficient in a single cytokine or immune cell population. Journal of Urology 159(5 Suppl): 309
Van, Den, Bosch, J.F. 1998: Escherichia coli vaccine. Official Gazette of the United States Patent and Trademark Office Patents 1210(2): 1433
Gyles, C.L. 1994: Escherichia coli verotoxins and other cytotoxins. Gyles, C L Escherichia coli in domestic animals and humans 365-398
Topley, N.; Mackenzie, R.K.; Steadman, R.; Williams, J.D. 1989: Escherichia coli virulence and renal scarring. Journal of Infectious Diseases 160(6): 1081-1083
Bokete, T.; O'callahan C.; Clausen, C.; Tang, N.; Fritsche, T.; Tarr, P. 1992: Escherichia coli with enteropathogenic escherichia coli epec and shiga like toxin sltec sequences in seattle children a prospective study. Abstracts of the General Meeting of the American Society for Microbiology 92: 131
Somerville, J.E.; Cassiano, L.; Bainbridge, B.; Cunningham, M.D.; Darveau, R.P. 1996: Escherichia coli with myristate deficient lipopolysaccharide no longer stimulates human immune cells. Abstracts of the General Meeting of the American Society for Microbiology 96: 535
Sherratt, D.J.; Blakely, G.W.; Colloms, S.; May, G.; Roberts, J. 1992: Escherichia coli xerc recombinase is required for both plasmid stability and chromosomal segregation. Journal of Cellular Biochemistry Suppl (16 Part B): 109
Schaechter, M. 1992: Escherichia coli, general biology. Lederberg, J Encyclopedia of Microbiology, Vols 1-4: 4) 115-124
Bundy, B.C.; Franciszkowicz, M.J.; Swartz, J.R. 2008: Escherichia coli-based cell-free synthesis of virus-like particles. Biotechnology and Bioengineering 100(1): 28-37
Greenberg, S.S.; Xie, J.; Wang, Y.; Malinski, T.; Summer, W.R.; McDonough, K. 1994: Escherichia coli-induced inhibition of endothelium-dependent relaxation and gene expression and release of nitric oxide is attenuated by chronic alcohol ingestion. Alcohol 11(1): 53-60
Cryz, S.J.; Furer, E.P. 1994: Escherichia colio-polysaccharide-protein conjugate vaccine. Official Gazette of the United States Patent and Trademark Office Patents 1169(1): 374-375
Guentzel, M.N. 1991: Escherichia klebsiella enterobacter serratia citrobacter and proteus. Baron, S (Ed ) Medical Microbiology, Third Edition Xx+1340p Churchill Livingstone: New York, New York, Usa; London, England, Uk Illus 377-387
Spaulding, A.C.; Rothman, A.L. 1996: Escherichia vulneris as a cause of intravenous catheter-related bacteremia. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 22(4): 728-729
Gray, L.D. 1995: Escherichia, Salmonella, Shigella, and Yersinia. Murray, P R, Pfaller, M A, Tenover, F C, Yolken, R H, Baron, E J Manual of clinical microbiology, Sixth edition 450-456
Sharma, S.; Sankaran, R.; Gibbons, N.; Singhal, P.C. 1994: Escherichia-coli -macrophage interaction modulates growth of cultured rat mesangial cells. Journal of the American Society of Nephrology 5(3): 701
Tarr, P.I. 1993: Escherichia-coli O157H7 Historical, epidemiological and clinical aspects. Journal of Food Protection 56(10): 908
Lam, R.W.; Andersen, H.F.; Wade, A.G. 2008: Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials. International Clinical Psychopharmacology 23(4): 181-187
Robinson, R.G.; Jorge, R.E.; Moser, D.J.; Acion, L.; Solodkin, A.; Small, S.L.; Fonzetti, P.; Hegel, M.; Arndt, S. 2008: Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 299(20): 2391-2400
Alamy, S.; Wei Zhang; Varia, I.; Davidson, J.R.; Connor, K.M. 2008: Escitalopram in specific phobia: results of a placebo-controlled pilot trial. Journal of Psychopharmacology 22(2): 157-161
Petersén, A.; Wörtwein, G.; Gruber, S.H.M.; Mathé, A.A. 2008: Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neuroscience Letters 436(3): 305-308
Kim, B.-J.; Kang, K.-M.; Jung, S.Y.; Choi, H.-K.; Seo, J.-H.; Chae, J.-H.; Cho, E.-J.; Youn, H.-D.; Qin, J.; Kim, S.-T. 2008: Esco2 is a novel corepressor that associates with various chromatin modifying enzymes. Biochemical and Biophysical Research Communications 372(2): 298-304
Mustafa, T.; Qazi, S.A.; Khan, M.A. 1993: Escobora syndrome. JPMA (Journal of the Pakistan Medical Association) 43(7): 140-141
Sbardelotto, A.; Leandro, G.-Villar 2008: Escolha de cultivares de soja com base na composicao quimica dos graos como perspectiva para maximizacao dos lucros nas industrias processadoras. Ciencia Rural 38(3): 614-619
Macnab, A.J. 1989: Escort criteria for interhospital pediatric transports. Pediatric Research 25(4 Part 2): 40A
Bujes, C., S.; Verrastro, L. 2000: Escudos epidermicos supernumerarios a variacao na carapaca na tartaruga-tigre-dagua, Trachemys dorbigni Testudines, Emydidae. Revista Brasileira de Zoologia 24(3): 666-672
Watanabe, K.; Niimura, K.; Miyagawa, J. 1998: Esculetin derivatives and method for manufacture thereof, use thereof, and pharmaceutical composition. Official Gazette of the United States Patent and Trademark Office Patents 1209(1): 496
Watanabe, K.; Niimura, K.; Umekawa, K. 1995: Esculetin derivatives and pharmaceutical composition. Official Gazette of the United States Patent and Trademark Office Patents 1179(1): 390
Watanabe, K.; Niimura, K.; Yamazaki, T.; Maruoka, H. 1998: Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition. Official Gazette of the United States Patent and Trademark Office Patents 1208(4): 3293
Castiglioni Bruno 1942: Escursione allanfiteatro morenico della Brianza. Bollettino della Societa Geologica Italiana 60: 2-3
Goldfarb, D.; Fauth J M.; Farver, O.; Pechta, I. 1992: Eseem studies on the blue oxidases laccase and ascorbate oxidase. Journal of Inorganic Biochemistry 47(1): 50
Yoshii, T.; Astashkin, A.V.; Kawamori, A. 1998: Eseem study of the Mn multiline in 15N-labeled photosystem II. Plant and Cell Physiology 39(Suppl ): S14
Clarke, P.B.S.; Reuben, M.; El Bizri, H. 1993: Eserine blocks nicotinic responses in the rat CNS. Society for Neuroscience Abstracts 19(1-3): 1535
Colorado, G.; Hamel, P.; Rodewald, A.; Thogmartin, W. 2008: Esfuerzo cooperativo de el Grupo Ceruleo para determinar el rango no reproductivo de la Reinita Cerulea en Sur America. Ornitologia Neotropical 19(Suppl S): 521-529
Phillips, I.; Acar, J.; Baquero, F.; Bergan, T.; Forsgren, A.; Wiedemann, B. 1991: ESGAB breakpoint determination: clarithromycin. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 10(11): 993-994